Zobrazeno 1 - 10
of 268
pro vyhledávání: '"Seiya, Okuda"'
Autor:
Yusuke Kaida, Takatoshi Kambe, Shintaro Kishimoto, Yusuke Koteda, Kenji Suda, Ryo Yamamoto, Tetsurou Imai, Takuma Hazama, Yoshimi Takamiya, Ryo Shibata, Hidemi Nishida, Seiya Okuda, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-6 (2017)
Abstract Background The treatment of Kawasaki disease is controversial when intravenous immunoglobulin therapy fails, although it typically relies on combinations of prednisolone, infliximab, cyclosporine, and plasma exchange therapy. The goal of the
Externí odkaz:
https://doaj.org/article/bf3e01053b684b33ab0230e39e5a87ce
Publikováno v:
Journal of Renal Nutrition. 32:326-333
Objective Excess sodium intake is associated with volume overload and increased blood pressure. Therefore, to prevent future cardiovascular events, a sodium-restricted diet is strongly recommended for patients on maintenance hemodialysis (HD). Howeve
Publikováno v:
Nihon Toseki Igakkai Zasshi. 54:481-488
Autor:
Takuma Hazama, Kiyomi Koike, Ryo Shibata, Sakuya Ito, Yusuke Kaida, Nao Nakamura, Tomofumi Moriyama, Hirotane Chiba, Daisuke Wakasugi, Kei Fukami, Seiya Okuda, Yuka Kurokawa, Tetsurou Imai, Kengo Urae
Publikováno v:
CEN Case Reports. 8:205-211
A 65-year-old male patient with nephrotic syndrome was admitted to our hospital due to worsening systemic edema and purpura on the limbs. He had an impaired renal function, low serum complement level, and elevated rheumatoid factor level. He was posi
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89433 (2014)
BACKGROUND: Oxidative stress and smoking contribute to endothelial dysfunction. Iron might also play a role in oxidative stress generation and endothelial dysfunction. However, the involvement of iron in smoking-induced endothelial dysfunction in hea
Externí odkaz:
https://doaj.org/article/7526d525f66a4371b34764d6f0540fae
Autor:
Yosuke Nakayama, Miyuki Yokoro, Sakuya Ito, Kensei Taguchi, Ryotaro Ando, Takanori Matsui, Yuichiro Higashimoto, Seiji Ueda, Kei Fukami, Craig R. Brooks, Nana Yamada-Obara, Yusuke Kaida, Goh Kodama, Katsuhiko Asanuma, Seiya Okuda, Sho-ichi Yamagishi
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
Scientific Reports
Scientific Reports
The mineralocorticoid receptor (MR) and its downstream signaling play an important role in hypertensive renal injury. The interaction of advanced glycation end products (AGE) with their receptor (RAGE) is involved in the progression of renal disease.
Autor:
Nobutaka Nakamura, Sho-ichi Yamagishi, Yusuke Suzuki, Yuichiro Higashimoto, Seiji Ueda, Ryotaro Ando, Maki Matsukuma-Toyonaga, Takanori Matsui, Kei Fukami, Kumiko Kaifu, Nana Yamada-Obara, Seiya Okuda, Yusuke Kaida, Masami Nakata
Publikováno v:
Microvascular research. 120
We have previously shown that albuminuria and renal levels of advanced glycation end products (AGEs), receptor for AGEs (RAGE), and oxidative stress are suppressed in dipeptidyl peptidase-4 (DPP-4)-deficient diabetic rats, thus suggesting the crossta
Publikováno v:
Journal of Diabetes and its Complications. 29:913-917
Objective Diabetic patients with severe chronic kidney disease (CKD) not treated with dialysis falsely show low levels of HbA1c and GA due to renal anemia and proteinuria, respectively. Recently, we reported that serum albumin-adjusted GA (adjGA) acc
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 52:488-496
Backgrounds Diabetic patients with end-stage renal disease who are not on haemodialysis show low concentrations of HbA1c and glycated albumin due to renal anaemia and proteinuria, respectively. In the present study, we examined whether serum albumin-
Autor:
Hidemi Nishida, Yoshimi Takamiya, Ryo Yamamoto, Shintaro Kishimoto, Seiya Okuda, Yusuke Koteda, Ryo Shibata, Kenji Suda, Takatoshi Kambe, Takuma Hazama, Yusuke Kaida, Kei Fukami, Tetsurou Imai
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-6 (2017)
Background The treatment of Kawasaki disease is controversial when intravenous immunoglobulin therapy fails, although it typically relies on combinations of prednisolone, infliximab, cyclosporine, and plasma exchange therapy. The goal of the treatmen